These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 915214)

  • 1. [Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases].
    Hartemann P; Leclere J; Groussin M; Valdenaire JC; Maureira JJ; Belleville F; Nabet P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Jun; 6(4):537-46. PubMed ID: 915214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM; Kletzky OA; Davajan V
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
    Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the action of bromocriptine in hyperprolactinemic states. Results of a cooperative trial in 135 patients].
    Fossati P; Strauch G; Tourniaire J
    Nouv Presse Med; 1976 Jul 3-10; 5(27):1687-91. PubMed ID: 986640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Shapiro AG
    South Med J; 1977 Jun; 70(6):720-1, 725. PubMed ID: 577621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine-induced pregnancies in the amenorrhoea-galactorrhoea syndrome.
    Mustaffa BE; Khalid BA; Satgunasingam N; Adeeb N; Tan PL; Chandran S
    Med J Malaysia; 1983 Sep; 38(3):237-43. PubMed ID: 6672568
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ; Geiger W; Schulz KD; Lose KH
    Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome.
    Corenblum B; Taylor PJ
    Fertil Steril; 1978 Oct; 30(4):388-92. PubMed ID: 581377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
    Perry-Keene DA; Warne GL; Martin FI
    Med J Aust; 1976 Oct; 2(16):602-4. PubMed ID: 1036755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study.
    Friesen HG; Tolis G
    Clin Endocrinol (Oxf); 1977; 6 Suppl():91S-99S. PubMed ID: 617073
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M; Godó G; Morvay J
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C; Votino F; Mattera P; Montemagno U
    Minerva Ginecol; 1979 Apr; 31(4):273-80. PubMed ID: 572516
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE; Reighlin S
    N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bromocriptine treatment of infertile women with amenorrhoea--galactorrhoea].
    Nillius SJ; Skarin O
    Lakartidningen; 1977 Nov; 74(46):4110-2. PubMed ID: 926944
    [No Abstract]   [Full Text] [Related]  

  • 18. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
    Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status of the mammary glands in a persistent lactorrhea-amenorrhea syndrome].
    Bukhteeva NF; Mel'nichenko GA; Sviatov AV; Struchkova TIa
    Sov Med; 1984; (11):75-8. PubMed ID: 6395360
    [No Abstract]   [Full Text] [Related]  

  • 20. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
    Netter A; Netter AL; Gorins A
    Gynecologie; 1975; 26(2):141-5. PubMed ID: 1164955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.